News
Eli Lilly's new oral weight-loss pill, orforglipron, shows promise in late-stage trials across countries like India and the ...
Eli Lilly's new oral weight-loss pill, orforglipron, shows promise in late-stage trials across countries like India and the ...
4d
Lose It! on MSNCoping With Common Side Effects of GLP-1 MedicationsIf you are taking a weight loss medication such as Ozempic, Wegovy, or Zepbound for obesity or other health concerns, you may ...
Nearly two years after reporting successful results from a phase 3 trial of its oral version of injected obesity treatment ...
Novo Nordisk filed for approval of an oral, 25-mg formulation of its weight loss blockbuster “earlier this year,” according ...
2d
MedPage Today on MSNIsturisa's New Indication; Wegovy Pill Submitted to FDA; Type 5 Diabetes?Novo Nordisk submitted an oral version of the weight-loss formulation of semaglutide (Wegovy) for FDA approval, according to ...
Lilly trumpeted positive topline results from ACHIEVE-1 (NCT05971940) showing orforglipron to have met the trial’s primary ...
Looking for help burning fat and curbing your appetite? We compared the best w͏eight lo͏ss suppl͏ements, analyzing their ...
and Gabapentin tablets 600 mg (used to treat partial seizures, nerve pain from shingles and restless leg syndrome). The majority of the drugs were prescription only, meaning that most people ...
(mean 6.3); 82 patients were randomized to memantine (10 mg/day) and 84 were randomized to placebo. Overall outcomes significantly favored the treatment group on measures of global assessment and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results